How to Buy Medpace Holdings Stock
Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Medpace Holdings stock last closed at $296.28, down 0.07% from the previous day, and has decreased 22.53% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.06 percentage points. Medpace Holdings stock is currently +8.93% from its 52-week low of $272.00, and -35.56% from its 52-week high of $459.77.
There are currently 30.47M shares of MEDP outstanding. The market value of MEDP is $9.03B. In the past 24 hours, 698,291 MEDP shares were traded.
How to Buy Medpace Holdings Stock
Wondering how to invest in Medpace Holdings stock? Here's how.
- Figure out where to buy Medpace Holdings stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Medpace Holdings stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your investment account: Select your method of payment and add your information.
- Evaluate Medpace Holdings stock: The Medpace Holdings ticker symbol is MEDP. Is Medpace Holdings stock a good investment? Should you buy shares of MEDP? How do MEDP's underlying business fundamentals look? Do top analysts think Medpace Holdings is a good buy? Why has MEDP's stock price moved recently? (Hint: Our stock research website can help you understand if MEDP is a good stock to buy).
- Execute your MEDP buy order: Decide if you will purchase MEDP shares at the current market price or use a limit order to purchase MEDP shares at a given price.
- Watch your MEDP investment: Create a watchlist to important updates regarding your position in Medpace Holdings stock.
Step 1: Figure out where to buy Medpace Holdings stock
You will need an online brokerage account in order to access the NASDAQ market and buy MEDP stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you are able to invest in MEDP today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new brokerage account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Watch the tutorial below if you need help transferring money into your new investment account.
Step 4: Evaluate Medpace Holdings stock
Once you have chosen the best place to buy Medpace Holdings stock, it's important to analyze their stock prior to buying, so you can comprehend the risk and upside.
Medpace Holdings Metrics
Medpace Holdings Due Diligence Score
WallStreetZen was created to help part-time investors do better fundamental analysis in less time.
You can view all of the due diligence checks on MEDP's stock page.
How is MEDP stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge MEDP's intrinsic value.
Using relative valuations methods:
- MEDP may be undervalued based on its P/E ratio of 22.69x, relative to Diagnostics & Research industry P/E ratio of 36.04x
- MEDP may be overvalued based on its P/B ratio of 10.93x, relative to Diagnostics & Research industry P/B ratio of 3.26x
- MEDP could be overvalued based on its PEG ratio of 4.91x
You can do more valuation analysis on MEDP's stock here.
MEDP Financials at a glance
Passed Financial Due Diligence Checks:
- MEDP earnings of $450.93M is not enough to cover its interest payments.
- MEDP profit margin has gone up from 15% to 19.2% in the past year.
- There are more short-term assets than long-term liabilities on the MEDP balance sheet.
- MEDP's operating cash flow of $608.82M allows it to safely service it's debt of $126.23M.
Failed Financial Due Diligence Checks:
- MEDP has a relatively high debt to equity ratio of 1.55.
- There are more short-term liabilities than short-term assets on the MEDP balance sheet.
- Total MEDP debt is higher than 5 years ago, relative to shareholder equity.
Is MEDP stock a Buy, Hold, or Sell, according to analysts?
Out of 5 Equities analysts who track MEDP, the consensus analyst rating on Medpace Holdings is a Hold
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Medpace Holdings stock forecast page.
MEDP Technicals
How are MEDP Revenues/Earnings doing?
Last year, MEDP earnings were $404.39M. In the past five year, MEDP's earnings have gone up by 36.17% per year. This was faster than the Diagnostics & Research industry average of 8.57%.
Last year, MEDP revenue was $2.11B. Over the past 5 year, MEDP's revenue has increased by 19.62% per year. This was faster than the Diagnostics & Research industry average of 9.96%.
You can research MEDP's earnings and revenue performance here.
Latest Insiders Trades at MEDP
Over the past 12 months, executives and large shareholders at MEDP have bought more shares than they have sold.
August J. Troendle, CEO of MEDP, was the latest MEDP insider to buy. They bought $2,048,206.58 worth of MEDP shares on Mar 7, 2025.
Learn more about who owns MEDP shares here.
Can I get consistent income from MEDP stock?
No, Medpace Holdings doesn't provide an income stream by paying out dividends.
MEDP Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your MEDP buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and your broker will place your order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Watch your MEDP investment
Now that you own some MEDP shares, you'll want to keep up with your new shares.
Add MEDP to a watchlist to see the latest developments about your MEDP stock.
MEDP Feed
How to Buy Stock in Medpace Holdings
To summarize, here are the 6 steps to buy stock in Medpace Holdings:
- Figure out where to buy Medpace Holdings stock
- Open a brokerage account
- Fund your investment account
- Evaluate Medpace Holdings stock
- Execute your MEDP buy order
- Watch your MEDP investment
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Medpace Holdings, click the button below.
Other "How To" Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.